Our year in numbers
![.](/assets/images/YIR-2023/3__ScaleMaxWidthWzQwMF0.97-million-01.png)
3.97 million
New Zealanders who received funded treatments
![.](/assets/images/YIR-2023/22-01__ScaleMaxWidthWzQwMF0.png)
16
Number of medicines with widened access
![.](/assets/images/YIR-2023/290000-01__ScaleMaxWidthWzQwMF0.png)
290,000
Estimated number of people benefitting from widened access to treatments.
![.](/assets/images/YIR-2023/20-01__ScaleMaxWidthWzQwMF0.png)
20
Number of new medicines funded
![.](/assets/images/YIR-2023/74000-01__ScaleMaxWidthWzQwMF0.png)
74,000
Estimated number of people benefitting from new treatments funded
![.](/assets/images/YIR-2023/1__ScaleMaxWidthWzQwMF0.186-billion-01.png)
$1.186 billion
Budget spent on medicines, related products, and vaccines (Combined Pharmaceutical Budget)
![.](/assets/images/YIR-2023/48__ScaleMaxWidthWzQwMF0.9-million-01.png)
$48.9 million
Money freed up from negotiations to reinvest in medicines, medical devices, and related products
![.](/assets/images/YIR-2023/10000-01__ScaleMaxWidthWzQwMF0.png)
10,000
Hospital medical devices added to the Pharmaceutical Schedule under national contracts
![.](/assets/images/YIR-2023/164000-01__ScaleMaxWidthWzQwMF0.png)
164,000
Hospital medical devices in the Pharmaceutical Schedule under national contracts
![.](/assets/images/YIR-2023/30-million-01__ScaleMaxWidthWzQwMF0.png)
$30 million
Value of additional hospital medical devices secured under contract
These statistics are from the 2022/23 financial year (1 July 2022 to 30 June 2023) not the calendar year.